Solvonis Therapeutics plc (LON:SVNS)

Revenue by Segment

Financials in millions GBP. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	May 31, 2021	May 31, 2020	May 31, 2019	May 31, 2018
Polymer Development and Production			587.00K	-	375.43K	520.00K	330.00K
Polymer Development and Production Growth			-	-	-27.80%	57.58%	1037.93%
Total			587.00K	-	375.43K	520.00K	330.00K
Total Growth			-	-	-27.80%	57.58%	1037.93%

Revenue by Geography

Financials in millions GBP. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	May 31, 2021	May 31, 2020	May 31, 2019	May 31, 2018
Slovenia			166.00K	127.00K	15.43K	214.00K	-
Slovenia Growth			30.71%	723.13%	-92.79%	-	-
Europe			355.00K	415.00K	274.29K	255.00K	-
Europe Growth			-14.46%	51.30%	7.56%	-	-
Rest of The World			66.00K	-	85.71K	51.00K	-
Rest of The World Growth			-	-	68.07%	-	-
Total			587.00K	542.00K	375.43K	520.00K	-
Total Growth			8.30%	44.37%	-27.80%	-	-

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jun 24, 2026

Data Sources Report a data error